Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Nine positive opinions for new drugs at CHMP meeting

Nine positive opinions for new drugs at CHMP meeting US. . The drug is a third-generation EGFR inhibitor, designed to overcome resistance to older drugs in the class such as Roche/Astellas' Tarceva (erlotinib), AZ's Iressa (gefitinib) and Boehringer

UK patients get early access to AZ's lung cancer drug Tagrisso

UK patients get early access to AZ's lung cancer drug Tagrisso The drug is a third-generation EGFR inhibitor, designed to overcome resistance to older drugs in the class such as Roche/Astellas' Tarceva (erlotinib), AZ's Iressa (gefitinib) and Boehringer

FDA clears Lilly's lung cancer drug Portrazza

FDA clears Lilly's lung cancer drug Portrazza Tarceva (erlotinib) and Boehringer Ingelheim's Giotrif (afatinib).

AZ sets price of new lung cancer drug Tagrisso

AZ sets price of new lung cancer drug Tagrisso The drug is a third-generation EGFR inhibitor, which is designed to overcome resistance to other drugs in the class such as Roche/Astellas' $2bn-a-year Tarceva (erlotinib), AZ's

Astellas sells dermatology unit to Leo for €675m

Astellas sells dermatology unit to Leo for €675m The overarching aim is to prepare for the forthcoming patent expiries on big-selling drugs Vesicare (solifenacin succinate) for overactive bladder and cancer therapy Tarceva (erlotinib).

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics